Patents Assigned to Sino-US Pficker Pharmaceuticals Co., Ltd.
  • Patent number: 8124139
    Abstract: The present invention discloses a compound preparation for quickly reducing oxidative stress, which contains small molecules and mineral trace elements that can remove or help removing free radicals, can regulate the function of endocrine and circulatory digestive system, as well as other components that can rebuild inner harmony. The compound preparation is in solid dosage form, preferably effervescent tablet or effervescent granules. The preparative method of the compound preparation is also disclosed. Animal experiment and clinical trial show that the invention has strong effect in reducing oxidative stress and disease prevention.
    Type: Grant
    Filed: April 23, 2007
    Date of Patent: February 28, 2012
    Assignee: Sino-US Pficker Pharmaceuticals Co., Ltd.
    Inventors: Hongping Yie, Meg M. Sun, Zuolin Zhu, Wei Sun, Zhongquan Zhao, Jinyuan Wang, Feng Zheng
  • Publication number: 20100105691
    Abstract: The present invention discloses a novel biguanidine compound, i.e. folacin-metformin, and its manufacture with inorganic salt of metformin as raw material. Compared with metformin, the compound has the same clinic curative effect, such as lowering blood sugar, curing poly-cystic ovary syndrome (PCOS), losing weight and so on, without resulting in the increase of homocysteine concentration, even with a little decrease of homocysteine concentration in some cases.
    Type: Application
    Filed: May 11, 2007
    Publication date: April 29, 2010
    Applicant: Sino-US Pficker Pharmaceuticals Co. Ltd.
    Inventors: Hongping Yie, Meg M. Sun, Zuolin Zhu